These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34860)

  • 1. [Effect of clofibrate on glucide tolerance in patients with ischemic heart disease and hyperlipoproteinemia].
    Bornemisza P; Csögör I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(6):543-6. PubMed ID: 34860
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differential diagnosis and differential treatment of carbohydrate tolerance disorders in patients with hyperlipoproteinemia. Behavior of plasma lipids, glucose tolerance, and plasma insulin after glucose load during treatment with clofibrate].
    Bruns W; Rjasanowski I; Wulfert P; Michael R; Knospe S; Hildmann W
    Endokrinologie; 1974 Nov; 64(1):2-12. PubMed ID: 4466653
    [No Abstract]   [Full Text] [Related]  

  • 3. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term treatment of hyperlipidemic patients with clofibrate.
    Berkowitz D
    JAMA; 1971 Nov; 218(7):1002-5. PubMed ID: 5000568
    [No Abstract]   [Full Text] [Related]  

  • 5. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
    Arntz HR; Klemens UH; Vollmar LJ; Lang PD
    Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias].
    Krivoruchenko IV; Nikul'cheva NG
    Kardiologiia; 1976 Jul; 16(7):71-5. PubMed ID: 185448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of clofibrate on glucose tolerance and insulin secretion in patients with endogenous hypertriglyceridemia (author's transl)].
    Schwandt P; Weisweiler P; Neureuther G; Wilkening J
    MMW Munch Med Wochenschr; 1976 Mar; 118(12):351-4. PubMed ID: 177863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on carbohydrate and lipid metabolism in cases of hyperlipidemia and coronary heart disease. I. Glucose tolerance test and lipid tolerance test.
    Chin Med J (Engl); 1978 Nov; 4(6):465-71. PubMed ID: 104838
    [No Abstract]   [Full Text] [Related]  

  • 10. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):66-71. PubMed ID: 768950
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperlipiemia and its therapy by clofibrate].
    Nakano M; Nakamura Y
    Iryo; 1969 Dec; 23(12):1473-8. PubMed ID: 5381198
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholesterol metabolism in patients with coronary heart disease.
    Miettinen TA
    Ann Clin Res; 1971 Dec; 3(6):313-22. PubMed ID: 5156891
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypolipidemic effect of tibric acid. A comparison with clofibrate and placebo in type IV hyperlipoproteinemia.
    Bielmann P; Brun D; Moorjani S; Gagnon MA; Tétreault L; Lupien PJ
    Int J Clin Pharmacol Biopharm; 1977 Apr; 15(4):166-71. PubMed ID: 192685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
    Koschinsky T; Gries FA; Schwandt P; Weisweiler P; Hansen W; Nijssen J; Beckmann R
    MMW Munch Med Wochenschr; 1977 May; 119(20):701-4. PubMed ID: 195201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
    Hanefeld M; Schulze J; Fritz T; Kemmer C
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:160 c. PubMed ID: 4200340
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypolipaemic drugs and coronary heart disease.
    Howard AN
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():106-14. PubMed ID: 783209
    [No Abstract]   [Full Text] [Related]  

  • 17. [Triglycerides, free fatty acids and cholesterol after fat loading and heparin injection in diabetics with and without hyperlipoproteinemia as well as after clofibrate treatment].
    Singer P; Gnauck G; Honigmann G; Thoelke H; Schliack V; Läuter J
    Dtsch Z Verdau Stoffwechselkr; 1977; 37(1):27-37. PubMed ID: 913315
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
    MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term management of various hyperlipidemias using clofibrate].
    Studlar M; Pichler O; Kindler K
    Wien Med Wochenschr; 1975 Dec; 125(50-52):746-51. PubMed ID: 1229130
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of clofibrate on glucose tolerance in patients with coronary heart disease.
    Ruzyllo E; Szostak WB; Cybulska B
    Pol Arch Med Wewn; 1972 Feb; 49(2):121-3. PubMed ID: 4670209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.